書籍情報から探す
Biochemical and Molecular Pharmacological Aspects of Transporters as Determinants of Drug Disposition
Yoshimichi SAI
Department of Pharmaceutics, Kyoritsu University of Pharmacy
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 91-99, 2005.
Department of Pharmaceutics, Kyoritsu University of Pharmacy
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 91-99, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Regional Difference in P-glycoprotein Function in Rat Intestine
Aiko IIDA, Mikio TOMITA, Masahiro HAYASHI
Department of Drug Absorption and Pharmacokinetics, School of Pharmacy, Tokyo University of Pharmacy and Life Science
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 100-106, 2005.
Department of Drug Absorption and Pharmacokinetics, School of Pharmacy, Tokyo University of Pharmacy and Life Science
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 100-106, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients
Masato TAGUCHI*1, Kazuhisa HONGOU*2, Shinichi YAGI*2, Toshio MIYAWAKI*2, Miwako TAKIZAWA*1, Tetsuya AIBA*1, Yukiya HASHIMOTO*1
*1 Graduate School of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, *2 Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 107-112, 2005.
*1 Graduate School of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, *2 Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 107-112, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
The Frequency of Candidate Alleles for CYP2D6 Genotyping in the Japanese Population with an Additional Respect to the -1584C to G Substitution
Yuka IKENAGA, Tsuyoshi FUKUDA, Kazuhiro FUKUDA, Yuko NISHIDA, Masakazu NAOHARA, Hiromi MAUNE, Junichi AZUMA
Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 113-116, 2005.
Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 113-116, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Effect of Isoniazid on the Pharmacodynamics of Cefazolin-Induced Seizures in Rats
Yasuyoshi ISHIWATA, Masashi NAGATA, Masato YASUHARA
Department of Hospital Pharmacy, School of Medicine, Tokyo Medical and Dental University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 117-120, 2005.
Department of Hospital Pharmacy, School of Medicine, Tokyo Medical and Dental University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 117-120, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Induction of Human CYP1A2 and CYP3A4 in Primary Culture of Hepatocytes from Chimeric Mice with Humanized Liver
Masuhiro NISHIMURA*1, Tsuyoshi YOKOI*2, Chise TATENO*3, Miho KATAOKA*3, Eiji TAKAHASHI*4, Toru HORIE*4*5, Katsutoshi YOSHIZATO*3*6, Shinsaku NAITO*1
*1 Division of Pharmacology, Drug Safety and Metabolism, Otsuka Pharmaceutical Factory, Inc., *2 Division of Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, *3 Hiroshima Prefectural Institute of Industrial Science and Technology, CLUSTER, *4 PhoenixBio Co., Ltd., *5 D three Research Laboratories, *6 Graduate School of Science, Hiroshima University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 121-126, 2005.
*1 Division of Pharmacology, Drug Safety and Metabolism, Otsuka Pharmaceutical Factory, Inc., *2 Division of Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, *3 Hiroshima Prefectural Institute of Industrial Science and Technology, CLUSTER, *4 PhoenixBio Co., Ltd., *5 D three Research Laboratories, *6 Graduate School of Science, Hiroshima University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 121-126, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Role of Human Liver Cytochrome P450 2C9 in the Metabolism of a Novel α4β1/α4β7 Dual Antagonist, TR-14035
Minoru TSUDA-TSUKIMOTO, Yuko OGASAWARA, Toshiyuki KUME
Exploratory DMPK, Exploratory Toxicology & DMPK Research Laboratories, Tanabe Seiyaku Co., Ltd.
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 127-134, 2005.
Exploratory DMPK, Exploratory Toxicology & DMPK Research Laboratories, Tanabe Seiyaku Co., Ltd.
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 127-134, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Urinary Excretion of Phenytoin Metabolites, 5-(4'-hydroxyphenyl)-5-Phenylhydantoin and its O-glucuronide in Humans and Analysis of Genetic Polymorphisms of UDP-glucuronosyltransferases
Hiroyuki YAMANAKA*1, Miki NAKAJIMA*1, Yusuke HARA*2, Miki KATOH*1, Osamu TACHIBANA*3, Junkoh YAMASHITA*3, Tsuyoshi YOKOI*1
*1 Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, *2 Kanazawa University Hospital, *3 Department of Neurosurgery, Division of Neuroscience, Graduate School of Medical Science, Kanazawa University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 135-143, 2005.
*1 Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, *2 Kanazawa University Hospital, *3 Department of Neurosurgery, Division of Neuroscience, Graduate School of Medical Science, Kanazawa University
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 135-143, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
Mayumi SAEKI*1, Yoshiro SAITO*1*2, Hideto JINNO*1*3, Kimie SAI*1*4, Akiko HACHISUKA*2, Nahoko KANIWA*1*5, Shogo OZAWA*1*6, Manabu KAWAMOTO*7, Naoyuki KAMATANI*7, Kuniaki SHIRAO*8, Hironobu MINAMI*9, Atsushi OHTSU*10, Teruhiko YOSHIDA*11, Nagahiro SAIJO*12, Kazuo KOMAMURA*13*14, Takeshi KOTAKE*15, Hideki MORISHITA*15, Shiro KAMAKURA*13, Masafumi KITAKAZE*13, Hitonobu TOMOIKE*13, Jun-ichi SAWADA*1*2
*1 Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan, *2 Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, Tokyo, Japan, *3 Division of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan, *4 Division of Xenobiotic Metabolism and Disposition, National Institute of Health Sciences, Tokyo, Japan, *5 Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan, *6 Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan, *7 Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's is Medical University, Tokyo, Japan, *8 Division of Internal Medicine, National Cancer Center Hospital, *11 Genetics Division, National Cancer Center Research Institute, National Cancer Center, Tokyo, Japan, *9 Division of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan, *10 Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba, Japan, *12 National Cancer Center Hospital East, Chiba, Japan, *13 Division of Cardiology, National Cardiovascular Center, Osaka, Japan, *14 Department of Cardiovascular Dynamics Research Institute, National Cardiovascular Center, Osaka, Japan, *15 Department of Pharmacy, National Cardiovascular Center, Osaka, Japan
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 144-151, 2005.
*1 Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan, *2 Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, Tokyo, Japan, *3 Division of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan, *4 Division of Xenobiotic Metabolism and Disposition, National Institute of Health Sciences, Tokyo, Japan, *5 Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan, *6 Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan, *7 Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's is Medical University, Tokyo, Japan, *8 Division of Internal Medicine, National Cancer Center Hospital, *11 Genetics Division, National Cancer Center Research Institute, National Cancer Center, Tokyo, Japan, *9 Division of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan, *10 Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba, Japan, *12 National Cancer Center Hospital East, Chiba, Japan, *13 Division of Cardiology, National Cardiovascular Center, Osaka, Japan, *14 Department of Cardiovascular Dynamics Research Institute, National Cardiovascular Center, Osaka, Japan, *15 Department of Pharmacy, National Cardiovascular Center, Osaka, Japan
DRUG METABOLISM AND PHARMACOKINETICS 20 (2) 144-151, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
